Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Committee

The Committees jointly did not support, by a vote of 1-Yes to 23-No, with no abstentions, the safety and efficacy of Purdue Pharma’s Avridi (oxycodone immediate-release tablets) for the management of moderate to severe pain where the use of an opioid analgesic is appropriate.